MedPath

Orfen-Plus

Brand Name: Orfen-Plus

Generic Name: Paracetamol + Oprhenadrine Citrate

Active
Registration Number

DRP-7458

Dosage Form

Tablet

Issuance Date

March 1, 2024

Expiry Date

April 29, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength450 mg/35 mg
PackagingAlu/Clear PVC Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Analgesic/Antipyretic/Muscle Relaxant
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

ParacetamolActive
Monograph: Acetaminophen
Oprhenadrine CitrateActive
Monograph: oprhenadrine citrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform